본문 바로가기
KERD
논문KCI 등재

Epidemiology of liver cancer in South Korea

Joong-Won Park|김보현
대한간학회 (The korean Association for the Study of the Liver)|2018.03|Clinical and Molecular Hepatology|제24권 제1호|pp. 1-9

2

조회

0

다운로드

41

인용

0

참고문헌

키워드

IncidenceEpidemiologyPrevalenceHepatocellular carcinomaLiver cancer

초록

Liver cancer is the sixth most common cancer (fourth in men and sixth in women) and the second largest cause of cancer mortality in South Korea. The crude incidence rate of liver cancer was 31.9/100,000 (47.5/100,000 in men and 16.2/100,000 in women) and the age-standardized incidence rate was 19.9/100,000 (32.4/100,000 in men and 8.8/100,000 in women) in 2014. The crude incidence rate increased from 1999 to 2011 and thereafter showed a subtle decreasing tendency. The crude prevalence rate was 113.6/100,000 (170.2/100,000 in men and 57.1/100,000 in women) and the age-standardized prevalence rate was 72.6/100,000 (115.7/100,000 in men and 33.7/100,000 in women) in 2014, which increased from 2010 to 2014. Survival from liver cancer has improved over the last two decades. The 5-year relative survival rate was markedly increased from 10.7% in those diagnosed with liver cancer between 1993 and 1995 to 32.8% in those diagnosed between 2010 and 2014. The epidemiology of liver cancer is influenced by that of underlying liver diseases such as viral hepatitis. Substantial progress has been made in the prevention and treatment of viral hepatitis; however, uncontrolled alcoholic liver disease, obesity and diabetes appears to have the potential to emerge as major causes for liver cancer. Depending on the success of the control of risk factors, the epidemiology of liver cancer in Korea may change.

Abstract

Liver cancer is the sixth most common cancer (fourth in men and sixth in women) and the second largest cause of cancer mortality in South Korea. The crude incidence rate of liver cancer was 31.9/100,000 (47.5/100,000 in men and 16.2/100,000 in women) and the age-standardized incidence rate was 19.9/100,000 (32.4/100,000 in men and 8.8/100,000 in women) in 2014. The crude incidence rate increased from 1999 to 2011 and thereafter showed a subtle decreasing tendency. The crude prevalence rate was 113.6/100,000 (170.2/100,000 in men and 57.1/100,000 in women) and the age-standardized prevalence rate was 72.6/100,000 (115.7/100,000 in men and 33.7/100,000 in women) in 2014, which increased from 2010 to 2014. Survival from liver cancer has improved over the last two decades. The 5-year relative survival rate was markedly increased from 10.7% in those diagnosed with liver cancer between 1993 and 1995 to 32.8% in those diagnosed between 2010 and 2014. The epidemiology of liver cancer is influenced by that of underlying liver diseases such as viral hepatitis. Substantial progress has been made in the prevention and treatment of viral hepatitis; however, uncontrolled alcoholic liver disease, obesity and diabetes appears to have the potential to emerge as major causes for liver cancer. Depending on the success of the control of risk factors, the epidemiology of liver cancer in Korea may change.

참고문헌 (27)

  1. Ferlay J, "Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012", Int J Cancer, 136, pp.E359~E386 (2015)[DOI]
  2. McGlynn KA, "Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability", Clin Liver Dis, 19, pp.223~238 (2015)[DOI]
  3. Annual report of cancer statistics in Korea in 2014, "Korea Central Cancer Registry", Ministry of Health and Welfare, ~ (2016)
  4. Lee BS, "Nationwide seroepidemiology of hepatitis B virus infection in South Korea in 2009 emphasizes the coexistence of HBsAg and anti-HBs", J Med Virol, 85, pp.1327~1333 (2013)[DOI]
  5. Kim DY, "A nationwide seroepidemiology of hepatitis C virus infection in South Korea", Liver Int, 33, pp.586~594 (2013)[DOI]
  6. Park JW, "Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study", Liver Int, 35, pp.2155~2166 (2015)[DOI]
  7. Kim BK, "Applicability of BCLC stage for prognostic stratification in comparison with other staging systems: single centre experience from long-term clinical outcomes of 1717 treatment-naive patients with hepatocellular carcinoma", Liver Int, 32, pp.1120~1127 (2012)[DOI]
  8. Kim BH, "Temporal Improvement in Survival of Patients with Hepatocellular Carcinoma in a Hepatitis B Virus-Endemic Population", J Gastroenterol Hepatol (2017)
  9. Kwak HW, "Clinical outcomes of a cohort series of patients with hepatocellular carcinoma in a hepatitis B virus-endemic area", J Gastroenterol Hepatol, 29, pp.820~829 (2014)[DOI]
  10. Young-Sun Lee, "Can More Aggressive Treatment Improve Prognosis in Patients with Hepatocellular Carcinoma? A Direct Comparison of the Hong Kong Liver Cancer and Barcelona Clinic Liver Cancer Algorithms", Gut and Liver, 12(1), pp.94~101 (2018), 거트앤리버 소화기연관학회협의회
  11. Lee SS, "Clinical features and outcome of cryptogenic hepatocellular carcinoma compared to those of viral and alcoholic hepatocellular carcinoma", BMC Cancer, 13, pp.335~ (2013)[DOI]
  12. Cho EJ, "Current status and strategies for hepatitis B control in Korea", Clin Mol Hepatol, 23, pp.205~211 (2017)[DOI]
  13. Sung JJ, "Meta-analysis: Treatment of hepatitis B infection reduces risk of hepatocellular carcinoma", Aliment Pharmacol Ther, 28, pp.1067~1077 (2008)[DOI]
  14. Choi J, "Increasing burden of liver cancer despite extensive use of antiviral agents in a hepatitis B virus-endemic population", Hepatology, 66, pp.1454~1463 (2017)[DOI]
  15. Forner A, "Hepatocellular carcinoma", Lancet, 379, pp.1245~1255 (2012)[DOI]
  16. Kim BK, "Current status of and strategies for hepatitis C control in South Korea", Clin Mol Hepatol, 23, pp.212~218 (2017)[DOI]
  17. European Association for the Study of the Liver, "EASL Recommendations on Treatment of Hepatitis C 2016", J Hepatol, 66, pp.153~194 (2017)[DOI]
  18. Ioannou GN, "HCV eradication induced by directacting antiviral agents reduces the risk of hepatocellular carcinoma", J Hepatol (2017)
  19. El-Serag HB, "Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?", Hepatology, 60, pp.1767~1775 (2014)[DOI]
  20. Mittal S, "Epidemiology of hepatocellular carcinoma: consider the population", J Clin Gastroenterol, 47(Suppl), pp.S2~S6 (2013)[DOI]
  21. Global status report on alcohol and health, "World Health Organization", Management of Substance Abus, ~ (2014)
  22. Cho EJ, "Relative etiological role of prior hepatitis B virus infection and nonalcoholic fatty liver disease in the development of non-B non-C hepatocellular carcinoma in a hepatitis B-endemic area", Digestion, 84(Suppl 1), pp.17~22 (2011)[DOI]
  23. Shim CW, "Noncirrhotic hepatocellular carcinoma: etiology and occult hepatitis B virus infection in a hepatitis B virus-endemic area", Therap Adv Gastroenterol, 10, pp.529~536 (2017)[DOI]
  24. 하경화, "Trends in the Diabetes Epidemic in Korea", Endocrinology and Metabolism, 30(2), pp.142~146 (2015), 대한내분비학회
  25. Statistics Korea, "Korean Statistical Information Service" (2017)
  26. Abello J, "Discrete Methods in Epidemiology", pp.1~260 (2007)
  27. Schottenfeld D, "Cancer Epidemiology and Prevention" (2006), Oxford University Press

관련 논문AI추천

Hepatocellular carcinoma incidence is decreasing in Korea but increasing in the very elderly전대원, 정승원, Donghee Son, Eileen Yoon, Han Pyo Hong, Jonghyun Lee, Sang Bong Ahn, Seong Yong Park, Soon Sun Kim, Young Eun Chon대한간학회 · Clinical and Molecular Hepatology2023 · 제29권 제1호Cause of death and cause-specific mortality for primary liver cancer in South Korea: A nationwide populationbased study in hepatitis B virus-endemic areaBo Hyun Kim, Dahhay Lee, Hyunsoon Cho, Kyu-Won Jung, Young-Joo Won대한간학회 · Clinical and Molecular Hepatology2022 · 제28권 제2호Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2014강윤식, 공현주, 권순석, 남해성, 오창모, 원영주, 이강현, 이덕형, 정규원, 홍남수, Chang-Hoon Kim, Cheol-In Yoo, Heon Kim, Jung-Ho Youm, Jung-Sik Huh, Moo-Kyung Oh, Woo-Chul Kim대한암학회 · Cancer Research and Treatment2017 · 제49권 제2호Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015공현주, 원영주, 이은숙, 정규원, The Community of Population-Based Regional Cancer Registries대한암학회 · Cancer Research and Treatment2018 · 제50권 제2호Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016공현주, 원영주, 이은숙, 정규원대한암학회 · Cancer Research and Treatment2019 · 제51권 제2호Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017공현주, 박영란, 원영주, 이은숙, 정규원, 홍세리, The Community of Population-Based Regional Cancer Registries대한암학회 · Cancer Research and Treatment2020 · 제52권 제2호

이 간행물의 다른 논문 (8건)

Current epidemiology and clinical characteristics of autoimmune liver diseases in South KoreaSook-Hyang Jeongpp. 10-19Prevention and management of gastroesophageal varicesYeon Seok Seopp. 20-42Role of liver transplantation in severe alcoholic hepatitisRavi Daswani, Praveen Sharma, Naresh Bansal, Anil Arora, Vikas Singla, Ashish Kumarpp. 43-50Clinical implication of hepatic volumetry for living donor liver transplantation정우경pp. 51-53Resection plane-dependent error in computed tomography volumetry of the right hepatic lobe in living liver donorsJeongjin Lee, Gi Won Song, So Yeon Kim, Sung Gyu Lee, 권헌주, Kyoung Won Kim, Bohyun Kim, Chul Seung Leepp. 54-60
원문 보기